Analytical Data
-
Gene name
HAPLN2
- Application
-
Alternative Names
HAPLN2;BRAL1;Hyaluronan and proteoglycan link Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9GZV7
-
Expression Region
27-340aa
-
AA Sequence
DPASHPGPHYLLPPIHEVIHSHRGATATLPCVLGTTPPSYKVRWSKVEPGELRETLILITNGLHARGYGPLGGRARMRRGHRLDASLVIAGVRLEDEGRYRCELINGIEDESVALTLSLEGVVFPYQPSRGRYQFNYYEAKQACEEQDGRLATYSQLYQAWTEGLDWCNAGWLLEGSVRYPVLTARAPCGGRGRPGIRSYGPRDRMRDRYDAFCFTSALAGQVFFVPGRLTLSEAHAACRRRGAVVAKVGHLYAAWKFSGLDQCDGGWLADGSVRFPITTPRPRCGGLPDPGVRSFGFPRPQQAAYGTYCYAEN
-
Molecular Weight
40.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HAPLN2 (Hyaluronan-Interacting Protein 2) is a member of the HAPLN family, which plays a critical role in the extracellular matrix (ECM) organization and maintenance. The protein is known for its ability to interact with hyaluronic acid, a major component of the ECM, thereby influencing tissue structure and function. Studies have indicated that HAPLN2 is involved in various physiological processes, including cell adhesion, migration, and proliferation. Aberrant expression of HAPLN2 has been associated with several pathological conditions, including cancer progression and various inflammatory diseases. Given its significance in ECM dynamics and potential implications in disease, HAPLN2 has become an important target for research aimed at understanding ECM-related disorders and developing therapeutic strategies. Recombinant HAPLN2 protein has been produced for further studies, facilitating detailed investigations into its biological functions, interactions, and role in disease mechanisms. This research is not only pivotal for advancing our understanding of HAPLN2 in a physiological context but also for exploring its potential as a biomarker or therapeutic target in various diseases.











